Kinnate Biopharma Inc.
Inhibitors of fibroblast growth factor receptor kinases

Last updated:

Abstract:

Provided herein are heteroaryl inhibitors of fibroblast growth factor receptor kinases, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.

Status:
Grant
Type:

Utility

Filling date:

4 Jun 2021

Issue date:

31 May 2022